StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Medpace's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $377.94M in fiscal 2015.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$50.00M–
FY2021Dec 31, 2021$0–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$79.72M-64.0%
FY2017Dec 31, 2017$221.61M+35.4%
FY2016Dec 31, 2016$163.64M-56.7%
FY2015Dec 31, 2015$377.94M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$55.00M-78.0%
Q1 FY2023Mar 31, 2023$115.00M–
Q4 FY2022Dec 31, 2022$50.00M–
Q3 FY2022Sep 30, 2022$139.70M–
Q2 FY2022Jun 30, 2022$249.70M–
Q4 FY2021Dec 31, 2021$0-100.0%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$55.78M-71.8%
Q4 FY2018Dec 31, 2018$79.72M-64.0%
Q3 FY2018Sep 30, 2018$113.69M-38.4%
Q2 FY2018Jun 30, 2018$163.52M+3.7%
Q1 FY2018Mar 31, 2018$197.57M+23.0%
Q4 FY2017Dec 31, 2017$221.61M+35.4%
Q3 FY2017Sep 30, 2017$184.62M–
Q2 FY2017Jun 30, 2017$157.63M–
Q1 FY2017Mar 31, 2017$160.64M–
Q4 FY2016Dec 31, 2016$163.64M–

More Medpace figures

See a number that looks wrong?